DRI Healthcare Trust Reports Strong Q1 Earnings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy DHT?
Source: seekingalpha
- Strong Revenue Performance: DRI Healthcare Trust reported total income of $50.6 million in Q1, indicating robust growth momentum in the healthcare investment sector, which further solidifies its market position.
- Adjusted EBITDA Reaches $52.8 Million: The company reported an adjusted EBITDA of $52.8 million with a remarkable margin of 90%, demonstrating significant improvements in operational efficiency and profitability, thereby boosting investor confidence.
- Adjusted Cash Earnings per Unit: The adjusted cash earnings per unit stood at $0.68, reflecting the company's effectiveness in cash flow management, which is expected to positively influence future dividend policies.
- Slight Increase in Comprehensive Earnings: Comprehensive earnings amounted to $0.5 million, although the growth was modest, it still indicates the company's efforts in stabilizing earnings, potentially laying a foundation for future growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DHT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DHT
Wall Street analysts forecast DHT stock price to fall
2 Analyst Rating
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 17.850
Low
14.30
Averages
16.15
High
18.00
Current: 17.850
Low
14.30
Averages
16.15
High
18.00
About DHT
DHT Holdings, Inc. is an independent crude oil tanker company. Its primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of crude oil tankers in the Very Large Crude Carriers (VLCC) segment. The Company operates its vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. Its principal activity is the ownership and operation of a fleet of crude oil carriers. Its fleet consisted of approximately 23 VLCC crude oil tankers. The fleet operates globally on international routes. The Company's fleet comprises DHT Addax, DHT Antelope, DHT Gazelle, DHT Impala, DHT Appaloosa, DHT Mustang, DHT Bronco, DHT Colt, DHT Stallion, DHT Tiger, DHT Puma, DHT Panther, DHT Osprey, DHT Leopard, DHT Jaguar, DHT Taiga, DHT Sundarbans, and DHT Scandinavia, among others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Significant Stake Increase: DME Capital boosted its stake in Peloton from approximately 250,000 shares in Q4 2025 to over 10 million shares in Q1 2026, indicating strong confidence in Peloton's growth potential, which may positively impact its stock price.
- Sotera Health Holdings Raised: The fund increased its holdings in Sotera Health from about 250,000 shares to 2.1 million shares, reflecting an optimistic outlook on the company's business prospects, potentially enhancing market confidence in Sotera.
- New Investment Positions: DME Capital initiated new positions in several emerging companies, including Dauch with 6.31 million shares, StubHub with 4.23 million shares, and Paramount Skydance with 3.93 million shares, demonstrating a strategic intent to diversify its investments, which may enhance overall portfolio returns.
- Exit from Multiple Investments: The fund completely exited positions in Kyndryl, Warner Bros. Discovery, United Parks & Resorts, and Global Payments, reflecting its keen insight into market dynamics and the ability to flexibly adjust its investment strategy.
See More
- Quarterly Dividend Announcement: DRI Healthcare Trust has declared a quarterly dividend of $0.11 per share, consistent with previous distributions, indicating stable cash flow and profitability, which enhances investor confidence.
- Payment Schedule: The dividend will be payable on July 20, with a record date of June 30 and an ex-dividend date also on June 30, ensuring shareholders receive their returns promptly, thereby reinforcing shareholder loyalty.
- Dividend Stability: This dividend level reflects DRI Healthcare Trust's robust performance in the current economic climate, demonstrating the company's commitment to returning value to shareholders while maintaining profitability, which enhances its competitive position in the market.
- Future Outlook: With a continued focus on financial health and shareholder returns, the company is expected to maintain or potentially increase dividends in the future, attracting more investor interest in its long-term growth potential.
See More
- Strong Revenue Performance: DRI Healthcare Trust reported total income of $50.6 million in Q1, indicating robust growth momentum in the healthcare investment sector, which further solidifies its market position.
- Adjusted EBITDA Reaches $52.8 Million: The company reported an adjusted EBITDA of $52.8 million with a remarkable margin of 90%, demonstrating significant improvements in operational efficiency and profitability, thereby boosting investor confidence.
- Adjusted Cash Earnings per Unit: The adjusted cash earnings per unit stood at $0.68, reflecting the company's effectiveness in cash flow management, which is expected to positively influence future dividend policies.
- Slight Increase in Comprehensive Earnings: Comprehensive earnings amounted to $0.5 million, although the growth was modest, it still indicates the company's efforts in stabilizing earnings, potentially laying a foundation for future growth.
See More
- Exit Transaction: 1492 Capital Management liquidated its entire position in DHT Holdings by selling 333,051 shares in Q1 2026, valued at approximately $5.30 million, indicating a strategy to lock in gains after a nearly 90% stock price surge.
- Quarterly Performance: DHT Holdings reported a profit of $66.1 million in Q4 2026, up from $54.7 million a year earlier, demonstrating the company's ability to remain profitable amidst a strong charter market.
- Price Volatility: As of April 21, 2026, DHT shares were priced at $17.99, reflecting a 90% increase over the past year; however, shipping revenue fell year-over-year in 2025, suggesting some market uncertainty.
- Future Outlook: While management continues to invest in new vessels and commits to returning 100% of ordinary earnings to shareholders, future returns will depend on the sustainability of elevated charter rates, prompting investors to carefully assess market dynamics.
See More
- Airbnb Upgrade: Wells Fargo upgraded Airbnb from equal weight to overweight, projecting revenue growth of 6% to 11% and EPS growth of 7% to 12% by 2027, indicating strong innovation and market potential.
- Positive Outlook for SharonAI: Compass Point initiated coverage on SharonAI with a buy rating, highlighting that its first major contract will drive scale and that its Australian capacity build provides a credible market base for deployment.
- Biogen's Multiple Catalysts: UBS upgraded Biogen to buy with a price target of $225, citing increasing confidence in several pipeline catalysts expected to drive stock price higher over the next 12-15 months.
- Twilio's Strategic Improvement: Bank of America upgraded Twilio from underperform to buy with a price target of $190, believing its strategic positioning in AI will lead to positive growth inflections for the company.
See More
- Rating Downgrades: Evercore ISI downgraded DHT Holdings and Frontline from Outperform to In-Line, while Nordic American Tanker was cut from In-Line to Underperform, reflecting a cautious outlook on the tanker sector's future.
- Market Dynamics: Although spot rates are at record highs, analysts noted that the parabolic rise over the past two months has been driven by the anomalous factor of the Strait of Hormuz closure, which may lead to future earnings uncertainty.
- Earnings Outlook: Evercore analyst Jonathan Chappell indicated that investor skepticism regarding an eventual resolution to Iranian hostilities has resulted in lackluster follow-through in tanker stocks, potentially leading to profit-taking.
- Demand Risks: Despite VLCC orders hitting a record in Q1, analysts warn that rising oil prices could threaten demand growth, particularly when the Middle East conflict concludes, posing greater downside risks to utilization.
See More











